My Quote Request
No products added yet
6505-01-582-1685
20 Products
NDC51079-0161-20
CODEINE PHOSPHATE A
NSN, MFG P/N
6505015821685
NSN
6505-01-582-1685
MFG
UDL LABORATORIES INC
Description
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE III
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN AND CODEINE TABS 300MG-30MG BLISTER PACK UNIT DOSE 100S
SPECIAL FEATURES: 300 MG ACETAMINOPHEN AND 30 MG CODEINE PHOSPHATE ACTIVE INGREDIENTS; UNIT DOSE TABLETS; BLISTER PACKED; 100 TABLETS PER PACKAGE; DEA CONTROLLED SUBSTANCE SCHEDULE III DRUG
Related Searches:
6505NCM104259
CODEINE PHOSPHATE A
NSN, MFG P/N
6505015821685
NSN
6505-01-582-1685
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE III
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN AND CODEINE TABS 300MG-30MG BLISTER PACK UNIT DOSE 100S
SPECIAL FEATURES: 300 MG ACETAMINOPHEN AND 30 MG CODEINE PHOSPHATE ACTIVE INGREDIENTS; UNIT DOSE TABLETS; BLISTER PACKED; 100 TABLETS PER PACKAGE; DEA CONTROLLED SUBSTANCE SCHEDULE III DRUG
Related Searches:
MBEU149684
ANTIGEN,KAHN PRECIPITATION TEST
NSN, MFG P/N
6505015822452
NSN
6505-01-582-2452
MBEU149684
ANTIGEN,KAHN PRECIPITATION TEST
NSN, MFG P/N
6505015822452
NSN
6505-01-582-2452
MFG
NAVAL AIR SYSTEMS COMMAND
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TEXT FIXTURE NACES
SPECIAL FEATURES: USED BY THE CANADIAN ARMED FORCES
Related Searches:
MBEU149685
ANTIGEN,KAHN PRECIPITATION TEST
NSN, MFG P/N
6505015822453
NSN
6505-01-582-2453
MBEU149685
ANTIGEN,KAHN PRECIPITATION TEST
NSN, MFG P/N
6505015822453
NSN
6505-01-582-2453
MFG
NAVAL AIR SYSTEMS COMMAND
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TEST FIXTURE SJU 5/6
SPECIAL FEATURES: USED BY CANADIAN ARMED FORCES
Related Searches:
ELH-NT3-001
ASSAY,ENZYME LINKED
NSN, MFG P/N
6505015823787
NSN
6505-01-582-3787
MFG
RAYBIOTECH INC.
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: ENZYME LINKED ASSAY KIT, IMMUNOABSORBENT TO MEASURE HUMAN NT-3, NEUROTROPHIN 3 PROTEIN GROWTH FACTOR FOR CENTRAL NERVOUS SYSTEM. ENCOURAGES GROWTH OF NEW NEURONS/SYNAPSES (NEUROGENESIS) IN BRAIN STEM CELLS; 96 WELL PLATE; SOLUTION CHANGES COLOR FROM BLUE
~1: TO YELLOW; URINE, PLASMA AND CELL SUPERNATANTS; STORE UP TO 6 MONTHS AT 2 TO 8 DEG C
Related Searches:
15879
MENINGOCOCCAL GROUP
NSN, MFG P/N
6505015825875
NSN
6505-01-582-5875
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEN GROUPS A C Y AND W-135 OLIGOSACCHARIDE DIPH CRM CONJUGATE VACCINE FOR INJ MENVEO 5S
III STORAGE TEMP RANGE: 2.0 TO 8.0 DEG CELSIUS
SPECIAL FEATURES: 1 VIAL CONTAINING LYOPHILIZED MEN. A CONJUGATE COMPONENT AND 1 VIAL CONTAINING LIQUID MEN CYW-135 CONJUGATE COMPONENT ACTIVE INGREDIENT; EACH DOSE CONSISTS OF THE RECONSTITUTION OF THE LYOPHILIZED MEN. A COMPONENT WITH THE LIQUID MEN. CYW-135 CONJUGATE
~1: COMPONENT, 0.5 ML SOLUTION FOR IM INJECTION; PACKAGE OF 5 VIALS LIQUID COMPONENT AND 5 VIALS OF LYOPHILIZED COMPONENT, SUFFICIENT FOR 5 SINGLE DOSES; FOR IM USE; FOR IMMUNIZATION OF PERSONS 11-55 YEARS OF AGE; USED TO PREVENT INVASIVE MENINGOCOCCAL
~2: DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135; DO NOT FREEZE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; REFRIGERATION IS ALSO REQUIRED DURING TRANSPORT; PROTECT FROM LIGHT
Related Searches:
6505NCM104263
MENINGOCOCCAL GROUP
NSN, MFG P/N
6505015825875
NSN
6505-01-582-5875
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEN GROUPS A C Y AND W-135 OLIGOSACCHARIDE DIPH CRM CONJUGATE VACCINE FOR INJ MENVEO 5S
III STORAGE TEMP RANGE: 2.0 TO 8.0 DEG CELSIUS
SPECIAL FEATURES: 1 VIAL CONTAINING LYOPHILIZED MEN. A CONJUGATE COMPONENT AND 1 VIAL CONTAINING LIQUID MEN CYW-135 CONJUGATE COMPONENT ACTIVE INGREDIENT; EACH DOSE CONSISTS OF THE RECONSTITUTION OF THE LYOPHILIZED MEN. A COMPONENT WITH THE LIQUID MEN. CYW-135 CONJUGATE
~1: COMPONENT, 0.5 ML SOLUTION FOR IM INJECTION; PACKAGE OF 5 VIALS LIQUID COMPONENT AND 5 VIALS OF LYOPHILIZED COMPONENT, SUFFICIENT FOR 5 SINGLE DOSES; FOR IM USE; FOR IMMUNIZATION OF PERSONS 11-55 YEARS OF AGE; USED TO PREVENT INVASIVE MENINGOCOCCAL
~2: DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135; DO NOT FREEZE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; REFRIGERATION IS ALSO REQUIRED DURING TRANSPORT; PROTECT FROM LIGHT
Related Searches:
MENVEO
MENINGOCOCCAL GROUP
NSN, MFG P/N
6505015825875
NSN
6505-01-582-5875
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEN GROUPS A C Y AND W-135 OLIGOSACCHARIDE DIPH CRM CONJUGATE VACCINE FOR INJ MENVEO 5S
III STORAGE TEMP RANGE: 2.0 TO 8.0 DEG CELSIUS
SPECIAL FEATURES: 1 VIAL CONTAINING LYOPHILIZED MEN. A CONJUGATE COMPONENT AND 1 VIAL CONTAINING LIQUID MEN CYW-135 CONJUGATE COMPONENT ACTIVE INGREDIENT; EACH DOSE CONSISTS OF THE RECONSTITUTION OF THE LYOPHILIZED MEN. A COMPONENT WITH THE LIQUID MEN. CYW-135 CONJUGATE
~1: COMPONENT, 0.5 ML SOLUTION FOR IM INJECTION; PACKAGE OF 5 VIALS LIQUID COMPONENT AND 5 VIALS OF LYOPHILIZED COMPONENT, SUFFICIENT FOR 5 SINGLE DOSES; FOR IM USE; FOR IMMUNIZATION OF PERSONS 11-55 YEARS OF AGE; USED TO PREVENT INVASIVE MENINGOCOCCAL
~2: DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135; DO NOT FREEZE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; REFRIGERATION IS ALSO REQUIRED DURING TRANSPORT; PROTECT FROM LIGHT
Related Searches:
NDC46028-0208-01
MENINGOCOCCAL GROUP
NSN, MFG P/N
6505015825875
NSN
6505-01-582-5875
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEN GROUPS A C Y AND W-135 OLIGOSACCHARIDE DIPH CRM CONJUGATE VACCINE FOR INJ MENVEO 5S
III STORAGE TEMP RANGE: 2.0 TO 8.0 DEG CELSIUS
SPECIAL FEATURES: 1 VIAL CONTAINING LYOPHILIZED MEN. A CONJUGATE COMPONENT AND 1 VIAL CONTAINING LIQUID MEN CYW-135 CONJUGATE COMPONENT ACTIVE INGREDIENT; EACH DOSE CONSISTS OF THE RECONSTITUTION OF THE LYOPHILIZED MEN. A COMPONENT WITH THE LIQUID MEN. CYW-135 CONJUGATE
~1: COMPONENT, 0.5 ML SOLUTION FOR IM INJECTION; PACKAGE OF 5 VIALS LIQUID COMPONENT AND 5 VIALS OF LYOPHILIZED COMPONENT, SUFFICIENT FOR 5 SINGLE DOSES; FOR IM USE; FOR IMMUNIZATION OF PERSONS 11-55 YEARS OF AGE; USED TO PREVENT INVASIVE MENINGOCOCCAL
~2: DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135; DO NOT FREEZE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; REFRIGERATION IS ALSO REQUIRED DURING TRANSPORT; PROTECT FROM LIGHT
Related Searches:
15909
ONDANSETRON HYDROCH
NSN, MFG P/N
6505015826395
NSN
6505-01-582-6395
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ONDANSETRON HCL ORAL DISINTEGRATING TABS 30S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 8 MG ONDANSETRON HYDROCHLORIDE PER TABLET; 30 TABLETS PER BOTTLE; ORALLY DISINTEGRATING RAPID RELEASE; STORE AT USP CONTROLLED ROOM TEMPERATURE; PROTECT FROM LIGHT
Related Searches:
6505NCM104271
ONDANSETRON HYDROCH
NSN, MFG P/N
6505015826395
NSN
6505-01-582-6395
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ONDANSETRON HCL ORAL DISINTEGRATING TABS 30S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 8 MG ONDANSETRON HYDROCHLORIDE PER TABLET; 30 TABLETS PER BOTTLE; ORALLY DISINTEGRATING RAPID RELEASE; STORE AT USP CONTROLLED ROOM TEMPERATURE; PROTECT FROM LIGHT
Related Searches:
NDC00378-7734-93
ONDANSETRON HYDROCH
NSN, MFG P/N
6505015826395
NSN
6505-01-582-6395
MFG
MYLAN PHARMACEUTICALS INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ONDANSETRON HCL ORAL DISINTEGRATING TABS 30S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 8 MG ONDANSETRON HYDROCHLORIDE PER TABLET; 30 TABLETS PER BOTTLE; ORALLY DISINTEGRATING RAPID RELEASE; STORE AT USP CONTROLLED ROOM TEMPERATURE; PROTECT FROM LIGHT
Related Searches:
GAMUNEX 10PCT
GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION
NSN, MFG P/N
6505015828651
NSN
6505-01-582-8651
GAMUNEX 10PCT
GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION
NSN, MFG P/N
6505015828651
NSN
6505-01-582-8651
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
SPECIAL FEATURES: IMMUNE GLOBULIN INTRAVENOUS THERAPY, 10 PCT STERILE SOLUTION; FOR PATIENTS W/IMMUNODEFICIENCY, CHRONIC INFLAMMATORY POLYNEUROPATHY OR PUPURA; IGIV THERAPY PROVIDES HEALTHY ANTIBODIES TO FIGHT INFECTIONS; DOES NOT CONTAIN SUCROSE, WHICH HAS BEEN LINKED TO
~1: KIDNEY FAILURE/DEATH; NATURAL AMINO ACID GLYCINE USED AS STABILIZER; MADE FROM HUMAN PLASMA; CAPRYLATE/CHROMATOGRAPHY PURIFIED; READ SAFETY DATA SHEETS FOR POSSIBLE REACTIONS/SIDE EFFECTS
Related Searches:
INVEGA 3MG
PALIPERIDONE
NSN, MFG P/N
6505015828662
NSN
6505-01-582-8662
MFG
ALZA CORP ALZA PHARMACEUTICALS DIV
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: ATYPICAL ANTIPSYCHOTIC FOR TREATING SCHIZOPHRENIA; MAY CAUSE HEART FAILURE, SUDDEN DEATH OR PNEUMONIA IN OLDER DEMENTIA PATIENTS; DERIVATIVE OF BENZISOXAZOLE; INSOLUABLE IN WATER; 3MG WHITE OVAL EXTENDED RELEASE TABLET FOR ORAL ADMINISTRATION
Related Searches:
INVEGA 6MG 28 TABLET
PALIPERIDON
NSN, MFG P/N
6505015829679
NSN
6505-01-582-9679
MFG
ALZA CORP ALZA PHARMACEUTICALS DIV
Description
III END ITEM IDENTIFICATION: PALIPERIDON
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PALIPERIDON
III SUPPLEMENTARY FEATURES: EXTENDED RELEASE TABLETS
SPECIAL FEATURES: 6 MG ( BEIGE)
Related Searches:
INVEGA 9MG 28 TABLET
PALIPERIDON
NSN, MFG P/N
6505015830211
NSN
6505-01-583-0211
MFG
ALZA CORP ALZA PHARMACEUTICALS DIV
Description
III END ITEM IDENTIFICATION: PALIPERIDON
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PALIPERIDON
III SUPPLEMENTARY FEATURES: ANTIPSYCHOTIC MEDICATION; PALIPERIDONE IS USED TO TREAT SCHIZOPHRENIA; STORE UP TO 25 DEGREES CELCIUS; EXCURSIONS PERMITTED 15 -30 DEGREES CELCIUS; PROTECT FROM MOISTURE
SPECIAL FEATURES: 9MG; COLOR: PINK
Related Searches:
GAMUNEX
GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION
NSN, MFG P/N
6505015830460
NSN
6505-01-583-0460
GAMUNEX
GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION
NSN, MFG P/N
6505015830460
NSN
6505-01-583-0460
MFG
QUEENS ECONOMIC DEVELOPMENT CORPORATION DBA QUEENS COUNTY ECONOMIC DEVELOPMENT
Description
SPECIAL FEATURES: IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% CAPRYLATE/CHROMOTOGRAPHY PURIFIED; FOR TREATMENT OF (PI)(ITP) AND (CIDP); MADE FROM HUMAN PLASMA
OXALIPLATIN 5MG/ML
ELOXATIN 50 MG 5MG
NSN, MFG P/N
6505015831148
NSN
6505-01-583-1148
OXALIPLATIN 5MG/ML
ELOXATIN 50 MG 5MG
NSN, MFG P/N
6505015831148
NSN
6505-01-583-1148
MFG
BEN VENUE LABORATORIES INC DBA BEDFORD LABORATORIES
Description
SPECIAL FEATURES: OXALIPLATIN SHOULD ONLY BE USED IN SPECIALIZED DEPARTMENTS OF ONCOLOGY AND SHOULD BE ADMINISTERED UNDER THE SUPERVISION OF AN EXPERIENCED ONCOLOGIST; MUST BE DILUTED BEFORE USE AND ADMINISTERED BY INTRAVENOUS INFUSION
Related Searches:
15989
BACITRACIN OPHTHALMIC OINTMENT,USP
NSN, MFG P/N
6505015834185
NSN
6505-01-583-4185
15989
BACITRACIN OPHTHALMIC OINTMENT,USP
NSN, MFG P/N
6505015834185
NSN
6505-01-583-4185
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE INGREDIENT AND STRENGTH: 5.000 BACITRACIN MILLIGRAMS PER GRAM
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN OPHTHALMIC OINTMENT USP 5MG BACITRACIN PER GRAM 3.5 GRAM TUBE 12S
MEDICAMENT BASE TYPE: MINERAL OIL-WHITE PETROLATUM
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 GRAMS
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: CONTAINS 500 UNITS BACITRACIN PER GRAM; KEEP TIGHTLY CLOSED; STORE AT ROOM TEMPERATURE; 3.5 GRAM TUBE; PACKAGE OF 12
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
6505NCM104273
BACITRACIN OPHTHALMIC OINTMENT,USP
NSN, MFG P/N
6505015834185
NSN
6505-01-583-4185
6505NCM104273
BACITRACIN OPHTHALMIC OINTMENT,USP
NSN, MFG P/N
6505015834185
NSN
6505-01-583-4185
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE INGREDIENT AND STRENGTH: 5.000 BACITRACIN MILLIGRAMS PER GRAM
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN OPHTHALMIC OINTMENT USP 5MG BACITRACIN PER GRAM 3.5 GRAM TUBE 12S
MEDICAMENT BASE TYPE: MINERAL OIL-WHITE PETROLATUM
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 GRAMS
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: CONTAINS 500 UNITS BACITRACIN PER GRAM; KEEP TIGHTLY CLOSED; STORE AT ROOM TEMPERATURE; 3.5 GRAM TUBE; PACKAGE OF 12
TOTAL PRIMARY CONTAINER QUANTITY: 12
